SCHEMBL12129191

SCHEMBL12129191

CCOc1ccccc1Cc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 5/20 0.63
DRD2 P14416 4/20 0.63
DRD3 P35462 4/20 0.63
HRH1 P35367 8/20 0.62
DRD4 P21917 4/20 0.62
DRD5 P21918 4/20 0.62
HPGD P15428 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
L3MBTL1 Q9Y468 3/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60
TSHR P16473 1/20 0.60
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
POLB P06746 1/20 0.54
ATM Q13315 1/20 0.54
HTR1A P08908 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15201690 0.89 L3MBTL1 (0.58) DRD1DRD2DRD3HRH1DRD4
SCHEMBL5254664 0.87 L3MBTL1 (0.64) DRD1DRD2DRD3HRH1DRD4
SCHEMBL28842716 0.87 L3MBTL1 (0.51) DRD1DRD2DRD3HRH1DRD4
SCHEMBL11293158 0.87 SLC5A1 (0.54) DRD1DRD2DRD3HRH1DRD4
SCHEMBL5248169 0.85 DRD1 (0.69) DRD1DRD2DRD3HRH1DRD4
SCHEMBL5146718 0.83 HRH1 (0.71) DRD1DRD2DRD3HRH1DRD4
SCHEMBL10601013 0.82 DRD2 (0.69) DRD1DRD2DRD3HRH1DRD4
SCHEMBL1602503 0.81 DRD1 (0.52) DRD1DRD2DRD3HRH1DRD4
SCHEMBL12772057 0.81 HRH1 (0.58) DRD1DRD2DRD3HRH1DRD4
SCHEMBL28360925 0.80 TP53 (0.69) DRD1DRD2DRD3HRH1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11952467-B2 Method for processing polyalkylene benzenedicarboxylate material NATIONAL TAIWAN UNIVERSITY (TW) 2024-04-09 US disclosed
CN-116515165-A Method for treating polyalkylene phthalate material 吴嘉文 2023-08-01 CN disclosed
CN-115515796-A Thermosensitive recording medium 王子控股株式会社 2022-12-23 CN disclosed
CN-102827122-B Glucoside derivate KBP BIOSCIENCES CO LTD 2015-01-14 CN disclosed
US-20110281837-A1 3-SUBSTITUTED-6-ARYL PYRIDINES HUTCHINSON ALAN J (US) 2011-11-17 US disclosed
US-7863454-B2 3-substituted-6-aryl pyridines NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2011-01-04 US disclosed
US-20090176980-A1 3-Substituted-6-Aryl Pyridines NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2009-07-09 US disclosed
US-7342115-B2 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology NEUROGEN CORPORATION (US) 2008-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110281837-A1 3-SUBSTITUTED-6-ARYL PYRIDINES C3AR1, C5AR1, C5AR2 DRD1 1459/4885DRD2 879/4885DRD3 878/4885
US-20090176980-A1 3-Substituted-6-Aryl Pyridines C3AR1, C5AR1, C5AR2 DRD1 1459/4885DRD2 879/4885DRD3 878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.